East Asian ACS patients tend to experience excessive inhibition of platelet function by potent P2Y12 inhibitors, significantly increasing the risk of major bleeding, suggesting a different ischemia/bleeding tradeoff to Caucasians [39]. This evidence concerns the gene P2RY12 and ischemia.